Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J, Rectal Cancer Consortium. · 2015
Read Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. by Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J, Rectal Cancer Consortium. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4619249.txt.
Description
J. Joshua Smith, together with colleagues, released a 2015 trial protocol on saving the rectum in locally advanced rectal cancer. Standard care mixes chemotherapy, radiation, and removal of the rectum, which impairs quality of life. Some patients' tumours vanish after drug and radiation treatment. The phase II trial tests whether those patients can safely skip surgery. The protocol appeared in BMC Cancer.
Patients receive chemotherapy either before or after chemoradiation, then are re-checked. Those with leftover tumour go to surgery, while complete responders are watched closely instead, with visits every three months for two years. Everyone is followed for at least five years, with three-year disease-free survival as the main measure. The design aims to prove that careful watching can match surgery for selected patients.
Catalog record
| CREATOR | Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J, Rectal Cancer Consortium. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |